- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
AstraZeneca's revenue from top product Nexium 2006-2018
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
AstraZeneca's revenue from top product Nexium 2006-2018
AstraZeneca's revenue from top product Nexium from 2006 to 2018 (in million U.S. dollars)
This statistic shows AstraZeneca's revenue from the top product Nexium between 2006 and 2018. AstraZeneca plc is one of the top 10 pharmaceutical companies worldwide. The multinational company is headquartered in London, UK. AstraZeneca is focused on products for following major disease areas: cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation. In 2006, revenue from Nexium amounted to around 5.18 billion U.S. dollars.
AstraZeneca's revenue from top product Nexium from 2006 to 2018 (in million U.S. dollars)
| Revenue in million U.S. dollars | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| Revenue in million U.S. dollars | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
This statistic shows AstraZeneca's revenue from the top product Nexium between 2006 and 2018. AstraZeneca plc is one of the top 10 pharmaceutical companies worldwide. The multinational company is headquartered in London, UK. AstraZeneca is focused on products for following major disease areas: cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation. In 2006, revenue from Nexium amounted to around 5.18 billion U.S. dollars.
Show more- Show sources information
- Show publisher information
- Release date
- March 2019
- Region
- Worldwide
- Survey time period
- 2006 to 2018
- Supplementary notes
- Figures for 2006-2015 were taken from previous annual reports.
- Open this statistic in...
Source
- Show sources information
- Show publisher information
- Release date
- March 2019
More information
- Region
- Worldwide
- Survey time period
- 2006 to 2018
- Supplementary notes
- Figures for 2006-2015 were taken from previous annual reports.
- Open this statistic in...
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Pharmaceutical brands: Crestor and Nexium (AstraZeneca)
- 38 page/s
- English
- pptx
- Detailed references
Everything On "Pharmaceutical brands: Crestor and Nexium (AstraZeneca)" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation
Statistics on "Pharmaceutical brands: Crestor and Nexium (AstraZeneca)"
- Overview
The most important statistics
- Top 15 pharmaceutical products by sales worldwide in 2018 (in million U.S. dollars)Top pharmaceutical products by sales worldwide 2018
- Top products of AstraZeneca based on revenue from 2015 to 2018 (in million U.S. dollars)AstraZeneca's top products based on revenue 2015-2018
- AstraZeneca's revenue fom top product Crestor from 2006 to 2018 (in million U.S. dollars)AstraZeneca's revenue from top product Crestor 2006-2018
- Top generic drugs based on savings in the United States in 2017 (in million U.S. dollars)Total savings of top generic drugs in U.S. 2017
- AstraZeneca's revenue from top product Nexium from 2006 to 2018 (in million U.S. dollars)AstraZeneca's revenue from top product Nexium 2006-2018
- Sales growth of leading brands of antacid tablets in the United States in 2018 (change to prior sales year)Sales growth of leading antacid tablet brands in the U.S. 2018
- Dollar sales share of the leading antacid tablet brands in the United States in 2018*U.S. dollar sales share of the leading antacid tablet brands 2018
- Drug prices and consumer behavior
The most important statistics
- Price disparities for top pharmaceutical product Nexium in the U.S. and abroad as of 2017 (in U.S. dollars per pill)*Price disparities for top product Nexium - U.S. and international 2017
- Esomeprazole out-of-pocket cost in the U.S. from 2004 to 2016 (in U.S. dollars)*Esomeprazole out of pocket cost U.S. 2004-2016
- Price disparities for pharmaceutical product Crestor in the U.S. and abroad as of 2017 (in U.S. dollars per pill)*Price disparities for top product Crestor - U.S. and international 2017
- Rosuvastatin calcium out-of-pocket cost in the U.S. from 2004 to 2016 (in U.S. dollars)*Rosuvastatin calcium out-of-pocket cost U.S. 2004-2016
- Advertising expenditures
The most important statistics
- AstraZeneca advertising spending in the United States from 2012 to 2017 (in million U.S. dollars)AstraZeneca: ad spend in the U.S. 2012-2017
- Leading pharmaceutical companies in the United States in 2017, by direct to consumer spending (in million U.S. dollars)Leading pharmaceutical companies in the U.S. 2017, by DTC
- Leading pharmaceutical companies in the United States between January and December 2018, by professional health print journals ad spend (in million U.S. dollars)Pharma companies with largest print ad spend in the U.S. 2018
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- AstraZeneca's revenue from top product Seroquel 2006-2018
- AstraZeneca's revenue from top product Pulmicort 2006-2018
- AstraZeneca's R&D expenditure as a percentage of revenue 2006-2018
- Average prices of Nexium - selected countries 2013
- AstraZeneca's operating profit 2006-2018
- AstraZeneca's revenue by therapeutic area 2015-2018
- AstraZeneca's revenue 2013-2018 by region
- AstraZeneca's expenditure on research and development 2006-2018
- AstraZeneca - number of animals used for research purposes 2006-2018
- AstraZeneca's employees by region 2018
- AstraZeneca - ad spend in the U.S. 2014, by medium
- World's top manufacturers of generic drugs based on revenue 2007
- Usage rate of top drug classes prescribed to seniors in Canada 2016, by location
- U.S. consumer feelings about direct-to-consumer pharmaceutical ads in 2017
- Revenue of top growing private specialty pharmacies in U.S. 2017
- Glucosamine market volume 2014-2022 in the U.S., by application
- Estonia: number of pharmaceutical preparations manufacturers 2008-2016
- Import value of vaccines to Algeria 2013-2015
- LabCorp SG&A expenses 2016-2018
- Global companies' environmental impacts by issue 2016
Studies
- Sobi Anual and sustainability report 2017
- Pharmaceutical industry in Italy
- Biotechnology in Germany
- Pharmaceutical trends in Europe
- PAGB Annual Review 2017-2018
- Teva - 2018 Form 10-K
- Indicatori Farmaceutici
- Novo Nordisk ANNUAL REPORT 2017
- Generic Pharmaceutical Industry Yearbook 2016
- Trends in Retail Prices of Prescription Drugs Widely Used by Older Americans, 2006 to 2013
Statistics on "Pharmaceutical brands: Crestor and Nexium (AstraZeneca)"
- Top 15 pharmaceutical products by sales worldwide in 2018 (in million U.S. dollars)
- Top products of AstraZeneca based on revenue from 2015 to 2018 (in million U.S. dollars)
- AstraZeneca's revenue fom top product Crestor from 2006 to 2018 (in million U.S. dollars)
- Top generic drugs based on savings in the United States in 2017 (in million U.S. dollars)
- AstraZeneca's revenue from top product Nexium from 2006 to 2018 (in million U.S. dollars)
- Sales growth of leading brands of antacid tablets in the United States in 2018 (change to prior sales year)
- Dollar sales share of the leading antacid tablet brands in the United States in 2018*
- Price disparities for top pharmaceutical product Nexium in the U.S. and abroad as of 2017 (in U.S. dollars per pill)*
- Esomeprazole out-of-pocket cost in the U.S. from 2004 to 2016 (in U.S. dollars)*
- Price disparities for pharmaceutical product Crestor in the U.S. and abroad as of 2017 (in U.S. dollars per pill)*
- Rosuvastatin calcium out-of-pocket cost in the U.S. from 2004 to 2016 (in U.S. dollars)*
- AstraZeneca advertising spending in the United States from 2012 to 2017 (in million U.S. dollars)
- Leading pharmaceutical companies in the United States in 2017, by direct to consumer spending (in million U.S. dollars)
- Leading pharmaceutical companies in the United States between January and December 2018, by professional health print journals ad spend (in million U.S. dollars)
- AstraZeneca's revenue from top product Seroquel from 2006 to 2018 (in million U.S. dollars)*
- AstraZeneca's revenue from top product Pulmicort from 2006 to 2018 (in million U.S. dollars)
- AstraZeneca's research & development expenditure as a percentage of total revenue from 2006 to 2018
- Average prices of Nexium in selected countries in 2013 (in U.S. dollars)
- AstraZeneca's operating profit from 2006 to 2018 (in million U.S. dollars)
- AstraZeneca's revenue from 2015 to 2018, by therapy area (in million U.S. dollars)
- AstraZeneca's revenue from 2013 to 2018, by region (in million U.S. dollars)
- AstraZeneca's expenditure on research and development from 2006 to 2018 (in million U.S. dollars)
- Number of animals used for research purposes by pharmaceutical company AstraZeneca from 2006 to 2018*
- Distribution of employees at AstraZeneca in 2018, by region
- AstraZeneca's direct-to-consumer (DTC) advertising spending in the United States in 2014, by medium (in million U.S. dollars)
- World's largest manufacturers of generic drugs based on revenue in 2007 (in million euros)
- Usage rate of top 10 drug classes prescribed to seniors in Canada in 2016, by geographic location*
- Percentage of U.S. consumers that felt select ways about direct-to-consumer (DTC) ads that address patient knowledge as of 2017
- Fastest-growing private specialty pharmacies in the U.S. in 2017, by revenue (in million U.S. dollars)
- Glucosamine market volume in the United States from 2014 to 2022, by application (in 1,000 metric tons)
- Number of enterprises in the manufacture of pharmaceutical preparations industry in Estonia from 2008 to 2016
- Value of vaccine imports to Algeria from 2013 to 2015 (in billion Saudi Arabian Riyal)
- Selling, general and administrative expenses of Laboratory Corporation of America from 2016 to 2018 (in million U.S. dollars)
- Distribution of natural capital impacts among companies worldwide in 2016, by issue
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.